Susan Spratt
Dr. Susan Spratt is a senior endocrinologist at Duke University Health System, known for her expertise in diabetes and metabolic health. In recent discussions, she praised the results of clinical trials involving semaglutide, particularly its ability to reduce liver inflammation and promote fibrosis regression in patients with liver disease.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Australia | 1 | 7.00 | 0.07% | +0% | 25,499,884 | 19,072 | $1,380,000 | 1,032$ |
| Totals | 1 | 25,499,884 | 19,072 | $1,380,000 | 1,032$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Australia:
Dr Susan Spratt is a professor of medicine at Duke University in North Carolina.
7
Israel:
Dr. Susan Spratt, an endocrinologist and senior medical director at Duke University Health System, expressed her impression of the study's results.
8